A Brain-Cancer Imaging First
Researchers at the University of Washington, Seattle have made the first imaging nanoparticle that can cross the blood-brain barrier. The nanoparticle, which specifically targets tumor cells, might help surgeons better pinpoint the boundaries of brain tumors.

The blood vessels that serve the brain are much more selective about what gets through than those feeding the rest of the body’s organs. This helps protect the brain from infection, but it also makes it difficult to get drugs and image-contrast agents inside the brain. The barrier can be temporarily broached using drugs, but at the risk of infection. This has made it difficult to apply recent developments in the field of molecular imaging, which uses targeted nanoparticles to light up tumor cells, to the brain. Targeted imaging could be particularly useful for imaging brain tumors, since these tend to be very invasive, infiltrating the surrounding brain tissue, making it difficult to remove them without damaging surrounding tissues, leading to cognitive problems.
The Seattle researchers developed a nanoparticle that is visible on magnetic resonance imaging scans and under the near-infrared light used by surgical microscopes. They tuned the particle’s properties–size, fat content, and electrical charge–so that it could cross the blood-brain barrier. It’s made up of an iron-oxide sphere coated with a fluorescent protein and a protein that’s targeted to tumor cells. When administered through a blood vessel to mice carrying brain tumors, the nanoparticle, which is described this week in the journal Cancer Research, improved contrast in brain imaging scans.
Keep Reading
Most Popular

Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.

These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.

Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.

A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
Stay connected

Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.